Figure 2From: Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patientsCategories of whole exome sequencing results returned to BASIC3 study families. PCG, pharmacogenetic; VUS, variant of uncertain significance.Back to article page